sulfadiazine has been researched along with Vesicoureteral Reflux in 2 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanson, E | 1 |
| Hansson, S | 1 |
| Jodal, U | 1 |
| Haahr, J | 1 |
2 other studies available for sulfadiazine and Vesicoureteral Reflux
| Article | Year |
|---|---|
Trimethoprim-sulphadiazine prophylaxis in children with vesico-ureteric reflux.
Topics: Anti-Infective Agents, Urinary; Child; Child, Preschool; Drug Combinations; Drug Resistance, Microbi | 1989 |
[Prognosis in vesico-ureteral reflux in children].
Topics: Ampicillin; Child; Child, Preschool; Escherichia coli; Female; Follow-Up Studies; Humans; Kidney; Ma | 1971 |